L18I

Customer Review

Based on 1 Customer Validation

L18I is a PROTAC targeting Btk that can reduce inflammation in autoimmune diseases such as lupus erythematosus induced by BM12 splenocytes. The active control of the target protein ligand of L18I is IBT6A-CO-ethyne (HY-163963), and the conjugate of E3 ubiquitin ligase ligand + Linker of L18I is Lenalidomide-C3-PEG3-N3 (HY-163964)[1].
(Pink: Btk ligand (HY-13036A); Blue: Cereblon ligand (HY-43722); Black: linker (HY-41921)).

For research use only. We do not sell to patients.

  • Purity: 99.43%
  • CAS No.: 2451070-32-7
  • Formula: C47H51N11O8
  • Molecular Weight:897.98
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00